In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Top Device Stories Of 2011: Living In A State Of Transition

Executive Summary

EBI’s device team reviews of the top news stories in the medical device industry in 2011. Top stories include: 510(k) reform, user-fees, VC money dries up for medtech, hot clinical spaces of the year, where private investment dollars went in 2011, big changes at J&J, and the new physician/hospital alignments and their impact on the medical device industry.

Advertisement

Related Content

Reverse Innovation: Is The US Losing Its Edge In Innovation?
Regulatory News In Brief
As TAVI Advances, Adjunctive Devices Multiply
A “Disastrous” Draft? Device Firms Take Issue With 510(k) Modifications Guidance
Mobile Health Promises To Uproot, Uplift Medical Devices
Spiracur Inc.
Cameron Health: Is This The Cure For An Ailing ICD Market?
Top Device Stories Of 2010: Waiting For The Other Shoes To Fall
Vertebral Compression Fracture Treatments Under Pressure
Covidien Runs Familiar But Different Plays to Build Vascular Franchise

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

IV003744

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel